After incubation of Δ9-tetrahydrocannabivarin with human hepatocytes, a major metabolic product was detected by gas chromatography-mass spectrometry that showed identical retention time and mass spectrum to the synthetic 11-nor-Δ9-tetrahydrocannabivarin-9-carboxylic acid (11-nor-Δ9-THCV-9-COOH). Analysis of human urine specimens from marijuana users and plasma samples from Marinol® users showed that 11-nor-Δ9-THCV-9-COOH was only present in urine specimens of marijuana users. These results supported the conclusion that identification of 11-nor-Δ9-THCV-9-COOH in a donor's urine specimen indicates the use or ingestion of cannabis-related product(s) and would not explain the sole use of Marinol.
CITATION STYLE
Elsohly, M. A., Feng, S., Murphy, T. P., Warrington, A. W., Ross, S., Nimrod, A., … Fortner, N. (2001). Identification and quantitation of 11-nor-Δ9-tetrahydrocannabivarin-9-carboxylic acid, a major metabolite of Δ9-tetrahydrocannabivarin. Journal of Analytical Toxicology, 25(6), 476–480. https://doi.org/10.1093/jat/25.6.476
Mendeley helps you to discover research relevant for your work.